ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I — Stella

Home/Mucopolysaccharidosis IH/S/

View on ClinicalTrials.gov

Recruiting

Back to Mucopolysaccharidosis IH/S trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United States

UCSF Benioff Children's Hospital Oakland, Oakland, California

University of Minnesota, Minneapolis, Minnesota

Key details

Phase

Early testing

Sponsor

Immusoft of CA, Inc.

Enrollment target

~11 participants

Started

April 2023

Primary completion

June 2029

Age range

10 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.